Rockwell Medical (RMTI) Cash & Current Investments (2010 - 2026)

Rockwell Medical's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $23.9 million for Q1 2026.

• Quarterly Cash & Current Investments rose 37.85% year-over-year to $23.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.9 million (up 37.85% YoY) and the FY2025 annual result came in at $25.0 million, up 15.72% from the prior year.
• Cash & Current Investments was $23.9 million for Q1 2026 at Rockwell Medical, down from $25.0 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $30.8 million in Q2 2022 and bottomed at $8.6 million in Q1 2024.
• A 5-year average of $18.4 million and a median of $18.3 million in 2024 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2022 — Cash & Current Investments plunged 78.54% — and 2025, when it soared 101.08%.
• Rockwell Medical's Cash & Current Investments stood at $21.5 million in 2022, then slumped by 49.12% to $10.9 million in 2023, then soared by 97.55% to $21.6 million in 2024, then gained by 15.72% to $25.0 million in 2025, then decreased by 4.43% to $23.9 million in 2026.
• Business Quant data shows RMTI's Cash & Current Investments at $23.9 million in Q1 2026, $25.0 million in Q4 2025, and $23.7 million in Q3 2025.